# Zydus Lifesciences enters exclusive negotiations to acquire majority stake in Amplitude Surgical

Zydus Lifesciences entered exclusive negotiations to acquire 85.6% of Amplitude Surgical at €6.25 per share, valuing the block at €256.8 million, with a mandatory tender offer for remaining shares.

- Type: Acquisition
- Announced: 2025-03-11
- Where: Valence, France, France
- Value: $280.0M (256.8M EUR)
- Status: announced
- Products: knee prostheses, hip prostheses
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [PAI Partners](https://endata.com/companies/2836.md) (investor)
- [Amplitude Surgical](https://endata.com/companies/49022.md) (target)
- [Zydus Lifesciences](https://endata.com/companies/83411.md) (acquirer)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20250311317385/en/Zydus-Enters-Exclusive-Negotiations-with-PAI-Partners-and-Other-Shareholders-to-Acquire-a-Majority-stake-in-Amplitude-Surgical-France), 2025-03-11: "Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical, France, at a price of €6.25 per Amplitude Surgical share."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.